Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
GNA12 and IL3RA guanine nucleotide binding protein (G protein) alpha 12 interleukin 3 receptor, alpha (low affinity)
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (12/13) signalling events
  • Platelet activation, signaling and aggregation
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • GPCR downstream signaling
  • Signaling by Interleukins
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Sargramostim
GNAI1 and GPR1 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 G protein-coupled receptor 1
  • Signaling by GPCR
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Signal amplification
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • GABA B receptor activation
  • Adenylate cyclase inhibitory pathway
  • GABA receptor activation
  • PLC beta mediated events
  • Opioid Signalling
  • Regulation of insulin secretion
  • G-protein mediated events
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Inhibition of adenylate cyclase pathway
  • Adenylate cyclase inhibitory pathway
  • GPCR downstream signaling
  • G-protein activation
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
GNAI1 and PTPRU guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 protein tyrosine phosphatase, receptor type, U
  • Signaling by GPCR
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Signal amplification
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • GABA B receptor activation
  • Adenylate cyclase inhibitory pathway
  • GABA receptor activation
  • PLC beta mediated events
  • Opioid Signalling
  • Regulation of insulin secretion
  • G-protein mediated events
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Inhibition of adenylate cyclase pathway
  • Adenylate cyclase inhibitory pathway
  • GPCR downstream signaling
  • G-protein activation
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • Signaling by SCF-KIT
GNAI2 and PTPRU guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 protein tyrosine phosphatase, receptor type, U
  • Signaling by GPCR
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Signal amplification
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • GABA B receptor activation
  • Adenylate cyclase inhibitory pathway
  • GABA receptor activation
  • PLC beta mediated events
  • Opioid Signalling
  • Regulation of insulin secretion
  • G-protein mediated events
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Inhibition of adenylate cyclase pathway
  • Adenylate cyclase inhibitory pathway
  • GPCR downstream signaling
  • G-protein activation
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • Signaling by SCF-KIT
GNAI3 and PTPRU guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 protein tyrosine phosphatase, receptor type, U
  • GABA B receptor activation
  • GABA receptor activation
  • Adenylate cyclase inhibitory pathway
  • Signaling by GPCR
  • PLC beta mediated events
  • Activation of GABAB receptors
  • G alpha (s) signalling events
  • Opioid Signalling
  • Signal amplification
  • G-protein mediated events
  • Inhibition of adenylate cyclase pathway
  • Adenylate cyclase inhibitory pathway
  • GPCR downstream signaling
  • G-protein activation
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Platelet activation, signaling and aggregation
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • Transmission across Chemical Synapses
  • Signaling by SCF-KIT
GNAO1 and PTPRU guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O protein tyrosine phosphatase, receptor type, U
  • Signaling by GPCR
  • Ca2+ pathway
  • PLC beta mediated events
  • G-protein activation
  • Opioid Signalling
  • Signaling by Wnt
  • G-protein mediated events
  • beta-catenin independent WNT signaling
  • Signaling by SCF-KIT
GNB1 and DISC1 guanine nucleotide binding protein (G protein), beta polypeptide 1 disrupted in schizophrenia 1
  • Signaling by GPCR
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 1
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Glucagon-type ligand receptors
  • G beta:gamma signalling through PLC beta
  • Signaling by Wnt
  • Metabolic disorders of biological oxidation enzymes
  • G protein gated Potassium channels
  • Olfactory Signaling Pathway
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Thromboxane signalling through TP receptor
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • Glucagon signaling in metabolic regulation
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Inwardly rectifying K+ channels
  • G-protein beta:gamma signalling
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Aquaporin-mediated transport
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Platelet homeostasis
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signal amplification
  • Potassium Channels
  • Activation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • G beta:gamma signalling through PI3Kgamma
  • The phototransduction cascade
  • G alpha (12/13) signalling events
  • Class B/2 (Secretin family receptors)
  • Prostacyclin signalling through prostacyclin receptor
  • GABA B receptor activation
  • GABA receptor activation
  • Activation of G protein gated Potassium channels
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Regulation of insulin secretion
  • GPCR ligand binding
  • beta-catenin independent WNT signaling
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Visual phototransduction
  • Ca2+ pathway
  • G-protein activation
GNB1 and HDAC4 guanine nucleotide binding protein (G protein), beta polypeptide 1 histone deacetylase 4
  • Signaling by GPCR
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 1
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Glucagon-type ligand receptors
  • G beta:gamma signalling through PLC beta
  • Signaling by Wnt
  • Metabolic disorders of biological oxidation enzymes
  • G protein gated Potassium channels
  • Olfactory Signaling Pathway
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Thromboxane signalling through TP receptor
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • Glucagon signaling in metabolic regulation
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Inwardly rectifying K+ channels
  • G-protein beta:gamma signalling
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Aquaporin-mediated transport
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Platelet homeostasis
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signal amplification
  • Potassium Channels
  • Activation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • G beta:gamma signalling through PI3Kgamma
  • The phototransduction cascade
  • G alpha (12/13) signalling events
  • Class B/2 (Secretin family receptors)
  • Prostacyclin signalling through prostacyclin receptor
  • GABA B receptor activation
  • GABA receptor activation
  • Activation of G protein gated Potassium channels
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Regulation of insulin secretion
  • GPCR ligand binding
  • beta-catenin independent WNT signaling
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Visual phototransduction
  • Ca2+ pathway
  • G-protein activation
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
GNG10 and TCF4 guanine nucleotide binding protein (G protein), gamma 10 transcription factor 4
  • Signaling by GPCR
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 1
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Glucagon-type ligand receptors
  • G beta:gamma signalling through PLC beta
  • Signaling by Wnt
  • Metabolic disorders of biological oxidation enzymes
  • G protein gated Potassium channels
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Thromboxane signalling through TP receptor
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • Glucagon signaling in metabolic regulation
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Inwardly rectifying K+ channels
  • G-protein beta:gamma signalling
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Aquaporin-mediated transport
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Platelet homeostasis
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signal amplification
  • Potassium Channels
  • G beta:gamma signalling through PI3Kgamma
  • G alpha (12/13) signalling events
  • Class B/2 (Secretin family receptors)
  • Prostacyclin signalling through prostacyclin receptor
  • GABA B receptor activation
  • GABA receptor activation
  • Activation of G protein gated Potassium channels
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Regulation of insulin secretion
  • GPCR ligand binding
  • beta-catenin independent WNT signaling
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Ca2+ pathway
  • G-protein activation
  • CDO in myogenesis
  • Myogenesis
GOLGA2 and HDAC4 golgin A2 histone deacetylase 4
  • Mitotic Prophase
  • Golgi Cisternae Pericentriolar Stack Reorganization
  • Cell Cycle, Mitotic
  • M Phase
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
GOLGA4 and TNIK golgin A4 TRAF2 and NCK interacting kinase
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
GPC1 and SLIT2 glypican 1 slit homolog 2 (Drosophila)
  • MPS IIIB - Sanfilippo syndrome B
  • Diseases of glycosylation
  • Defective B4GALT7 causes EDS, progeroid type
  • Axon guidance
  • Heparan sulfate/heparin (HS-GAG) metabolism
  • MPS I - Hurler syndrome
  • MPS IX - Natowicz syndrome
  • Chondroitin sulfate/dermatan sulfate metabolism
  • Defective SLC26A2 causes chondrodysplasias
  • Glycosaminoglycan metabolism
  • Inactivation of Cdc42 and Rac
  • Defective CHST14 causes EDS, musculocontractural type
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective PAPSS2 causes SEMD-PA
  • Activation of Rac
  • MPS IIIA - Sanfilippo syndrome A
  • Myoclonic epilepsy of Lafora
  • Defective CHST6 causes MCDC1
  • Glycogen storage diseases
  • MPS IIID - Sanfilippo syndrome D
  • A tetrasaccharide linker sequence is required for GAG synthesis
  • MPS IIIC - Sanfilippo syndrome C
  • Retinoid metabolism and transport
  • Role of Abl in Robo-Slit signaling
  • Diseases associated with glycosaminoglycan metabolism
  • Mucopolysaccharidoses
  • Defective EXT2 causes exostoses 2
  • MPS II - Hunter syndrome
  • Defective B3GAT3 causes JDSSDHD
  • Defective CHST3 causes SEDCJD
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Diseases associated with visual transduction
  • MPS IV - Morquio syndrome A
  • Visual phototransduction
  • MPS IV - Morquio syndrome B
  • Defective CHSY1 causes TPBS
  • MPS VII - Sly syndrome
  • Metabolism of carbohydrates
  • Signaling by Robo receptor
  • HS-GAG biosynthesis
  • HS-GAG degradation
  • MPS VI - Maroteaux-Lamy syndrome
  • Inactivation of Cdc42 and Rac
  • Role of Abl in Robo-Slit signaling
  • Axon guidance
  • Activation of Rac
  • Regulation of Commissural axon pathfinding by Slit and Robo
  • Netrin-1 signaling
  • Signaling by Robo receptor
GPC1 and COL18A1 glypican 1 collagen, type XVIII, alpha 1
  • MPS IIIB - Sanfilippo syndrome B
  • Diseases of glycosylation
  • Defective B4GALT7 causes EDS, progeroid type
  • Axon guidance
  • Heparan sulfate/heparin (HS-GAG) metabolism
  • MPS I - Hurler syndrome
  • MPS IX - Natowicz syndrome
  • Chondroitin sulfate/dermatan sulfate metabolism
  • Defective SLC26A2 causes chondrodysplasias
  • Glycosaminoglycan metabolism
  • Inactivation of Cdc42 and Rac
  • Defective CHST14 causes EDS, musculocontractural type
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective PAPSS2 causes SEMD-PA
  • Activation of Rac
  • MPS IIIA - Sanfilippo syndrome A
  • Myoclonic epilepsy of Lafora
  • Defective CHST6 causes MCDC1
  • Glycogen storage diseases
  • MPS IIID - Sanfilippo syndrome D
  • A tetrasaccharide linker sequence is required for GAG synthesis
  • MPS IIIC - Sanfilippo syndrome C
  • Retinoid metabolism and transport
  • Role of Abl in Robo-Slit signaling
  • Diseases associated with glycosaminoglycan metabolism
  • Mucopolysaccharidoses
  • Defective EXT2 causes exostoses 2
  • MPS II - Hunter syndrome
  • Defective B3GAT3 causes JDSSDHD
  • Defective CHST3 causes SEDCJD
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Diseases associated with visual transduction
  • MPS IV - Morquio syndrome A
  • Visual phototransduction
  • MPS IV - Morquio syndrome B
  • Defective CHSY1 causes TPBS
  • MPS VII - Sly syndrome
  • Metabolism of carbohydrates
  • Signaling by Robo receptor
  • HS-GAG biosynthesis
  • HS-GAG degradation
  • MPS VI - Maroteaux-Lamy syndrome
  • Collagen formation
  • Laminin interactions
  • Collagen degradation
  • Activation of Matrix Metalloproteinases
  • Integrin cell surface interactions
  • Collagen biosynthesis and modifying enzymes
  • Degradation of the extracellular matrix
  • Assembly of collagen fibrils and other multimeric structures
GPC1 and SLIT1 glypican 1 slit homolog 1 (Drosophila)
  • MPS IIIB - Sanfilippo syndrome B
  • Diseases of glycosylation
  • Defective B4GALT7 causes EDS, progeroid type
  • Axon guidance
  • Heparan sulfate/heparin (HS-GAG) metabolism
  • MPS I - Hurler syndrome
  • MPS IX - Natowicz syndrome
  • Chondroitin sulfate/dermatan sulfate metabolism
  • Defective SLC26A2 causes chondrodysplasias
  • Glycosaminoglycan metabolism
  • Inactivation of Cdc42 and Rac
  • Defective CHST14 causes EDS, musculocontractural type
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective PAPSS2 causes SEMD-PA
  • Activation of Rac
  • MPS IIIA - Sanfilippo syndrome A
  • Myoclonic epilepsy of Lafora
  • Defective CHST6 causes MCDC1
  • Glycogen storage diseases
  • MPS IIID - Sanfilippo syndrome D
  • A tetrasaccharide linker sequence is required for GAG synthesis
  • MPS IIIC - Sanfilippo syndrome C
  • Retinoid metabolism and transport
  • Role of Abl in Robo-Slit signaling
  • Diseases associated with glycosaminoglycan metabolism
  • Mucopolysaccharidoses
  • Defective EXT2 causes exostoses 2
  • MPS II - Hunter syndrome
  • Defective B3GAT3 causes JDSSDHD
  • Defective CHST3 causes SEDCJD
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Diseases associated with visual transduction
  • MPS IV - Morquio syndrome A
  • Visual phototransduction
  • MPS IV - Morquio syndrome B
  • Defective CHSY1 causes TPBS
  • MPS VII - Sly syndrome
  • Metabolism of carbohydrates
  • Signaling by Robo receptor
  • HS-GAG biosynthesis
  • HS-GAG degradation
  • MPS VI - Maroteaux-Lamy syndrome
  • Axon guidance
  • Netrin-1 signaling
GPC1 and VEGFA glypican 1 vascular endothelial growth factor A
  • MPS IIIB - Sanfilippo syndrome B
  • Diseases of glycosylation
  • Defective B4GALT7 causes EDS, progeroid type
  • Axon guidance
  • Heparan sulfate/heparin (HS-GAG) metabolism
  • MPS I - Hurler syndrome
  • MPS IX - Natowicz syndrome
  • Chondroitin sulfate/dermatan sulfate metabolism
  • Defective SLC26A2 causes chondrodysplasias
  • Glycosaminoglycan metabolism
  • Inactivation of Cdc42 and Rac
  • Defective CHST14 causes EDS, musculocontractural type
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective PAPSS2 causes SEMD-PA
  • Activation of Rac
  • MPS IIIA - Sanfilippo syndrome A
  • Myoclonic epilepsy of Lafora
  • Defective CHST6 causes MCDC1
  • Glycogen storage diseases
  • MPS IIID - Sanfilippo syndrome D
  • A tetrasaccharide linker sequence is required for GAG synthesis
  • MPS IIIC - Sanfilippo syndrome C
  • Retinoid metabolism and transport
  • Role of Abl in Robo-Slit signaling
  • Diseases associated with glycosaminoglycan metabolism
  • Mucopolysaccharidoses
  • Defective EXT2 causes exostoses 2
  • MPS II - Hunter syndrome
  • Defective B3GAT3 causes JDSSDHD
  • Defective CHST3 causes SEDCJD
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Diseases associated with visual transduction
  • MPS IV - Morquio syndrome A
  • Visual phototransduction
  • MPS IV - Morquio syndrome B
  • Defective CHSY1 causes TPBS
  • MPS VII - Sly syndrome
  • Metabolism of carbohydrates
  • Signaling by Robo receptor
  • HS-GAG biosynthesis
  • HS-GAG degradation
  • MPS VI - Maroteaux-Lamy syndrome
  • VEGF binds to VEGFR leading to receptor dimerization
  • Cellular response to hypoxia
  • VEGF ligand-receptor interactions
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Signaling by VEGF
  • Response to elevated platelet cytosolic Ca2+
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • Regulation of gene expression by Hypoxia-inducible Factor
  • Bevacizumab
  • Minocycline
  • Gliclazide
  • Carvedilol
  • Ranibizumab
  • Pyroglutamic Acid
  • Tris(Hydroxymethyl)Aminomethane
  • Vandetanib
  • Dalteparin
  • Aflibercept
GPR1 and TPST1 G protein-coupled receptor 1 tyrosylprotein sulfotransferase 1
GPR1 and TPST2 G protein-coupled receptor 1 tyrosylprotein sulfotransferase 2
CCR10 and PRRC2A chemokine (C-C motif) receptor 10 proline-rich coiled-coil 2A
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Chemokine receptors bind chemokines
  • Class A/1 (Rhodopsin-like receptors)
  • G alpha (i) signalling events
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
GRB2 and ITIH4 growth factor receptor-bound protein 2 inter-alpha-trypsin inhibitor heavy chain family, member 4
  • Pegademase bovine
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
GRB2 and PRRC2A growth factor receptor-bound protein 2 proline-rich coiled-coil 2A
  • Pegademase bovine
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid

Page 23 out of 82 pages